Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis

Steven A. Mazzuca, A. Robin Poole, Kenneth D. Brandt, Barry Katz, Kathleen A. Lane, Tatiana Lobanok

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective. We examined whether plasma concentrations of biomarkers of the collagenase cleavage of type II collagen (C2C), types I and II collagens (C1,2C), type II collagen synthesis (CPII), proteoglycan aggrecan turnover (CS846), and the ratio C2C:CPII would distinguish subjects with progressive radiographic osteoarthritis (OA) from those with stable disease. Methods. Subjects were 120 obese middle-aged women with unilateral knee OA who participated in a 30-month clinical trial of structure modification with doxycycline, in which a standardized semiflexed anteroposterior view of the knee was obtained at baseline, 16 months, and 30 months. Subjects were selected from a larger sample to permit a priori comparisons between 60 OA progressors and 60 non-progressors, as defined by joint space narrowing (JSN) in the medial tibiofemoral compartment. Each group contained 30 subjects who exhibited clinically significant increases in knee pain over 30 months and 30 who did not. Plasma samples were obtained every 6 months for determination of C2C, CPII, CS846, and C1,2C. Results. None of the biomarkers was a significant predictor of progression of JSN. Over the interval from baseline to 16 months, the mean and the maximum of the intercurrent CS846 values were significantly associated with JSN (i.e., 0.12-0.14 mm of JSN per SD decrease in mean or maximum CS846; p <0.01). The mean of serial CS846 levels was related to JSN also during the interval between months 16 and 30. Conclusion. Markers of type II collagen synthesis/degradation and of proteoglycan aggrecan turnover were not predictive of JSN in knee OA in this pilot study. However, serial concentrations of proteoglycan aggrecan epitope CS846 were associated with JSN during both the intervals studied.

Original languageEnglish (US)
Pages (from-to)1147-1151
Number of pages5
JournalJournal of Rheumatology
Volume33
Issue number6
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Knee Osteoarthritis
Proteoglycans
Collagen
Joints
Aggrecans
Collagen Type II
Osteoarthritis
Knee
Biomarkers
Doxycycline
Collagenases
Collagen Type I
Epitopes
Clinical Trials
Pain

Keywords

  • Biomarkers
  • Knee osteoarthritis
  • Type II collagen

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. / Mazzuca, Steven A.; Poole, A. Robin; Brandt, Kenneth D.; Katz, Barry; Lane, Kathleen A.; Lobanok, Tatiana.

In: Journal of Rheumatology, Vol. 33, No. 6, 06.2006, p. 1147-1151.

Research output: Contribution to journalArticle

Mazzuca, Steven A. ; Poole, A. Robin ; Brandt, Kenneth D. ; Katz, Barry ; Lane, Kathleen A. ; Lobanok, Tatiana. / Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. In: Journal of Rheumatology. 2006 ; Vol. 33, No. 6. pp. 1147-1151.
@article{a5d9da468bd94104a9478650e7738975,
title = "Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis",
abstract = "Objective. We examined whether plasma concentrations of biomarkers of the collagenase cleavage of type II collagen (C2C), types I and II collagens (C1,2C), type II collagen synthesis (CPII), proteoglycan aggrecan turnover (CS846), and the ratio C2C:CPII would distinguish subjects with progressive radiographic osteoarthritis (OA) from those with stable disease. Methods. Subjects were 120 obese middle-aged women with unilateral knee OA who participated in a 30-month clinical trial of structure modification with doxycycline, in which a standardized semiflexed anteroposterior view of the knee was obtained at baseline, 16 months, and 30 months. Subjects were selected from a larger sample to permit a priori comparisons between 60 OA progressors and 60 non-progressors, as defined by joint space narrowing (JSN) in the medial tibiofemoral compartment. Each group contained 30 subjects who exhibited clinically significant increases in knee pain over 30 months and 30 who did not. Plasma samples were obtained every 6 months for determination of C2C, CPII, CS846, and C1,2C. Results. None of the biomarkers was a significant predictor of progression of JSN. Over the interval from baseline to 16 months, the mean and the maximum of the intercurrent CS846 values were significantly associated with JSN (i.e., 0.12-0.14 mm of JSN per SD decrease in mean or maximum CS846; p <0.01). The mean of serial CS846 levels was related to JSN also during the interval between months 16 and 30. Conclusion. Markers of type II collagen synthesis/degradation and of proteoglycan aggrecan turnover were not predictive of JSN in knee OA in this pilot study. However, serial concentrations of proteoglycan aggrecan epitope CS846 were associated with JSN during both the intervals studied.",
keywords = "Biomarkers, Knee osteoarthritis, Type II collagen",
author = "Mazzuca, {Steven A.} and Poole, {A. Robin} and Brandt, {Kenneth D.} and Barry Katz and Lane, {Kathleen A.} and Tatiana Lobanok",
year = "2006",
month = "6",
language = "English (US)",
volume = "33",
pages = "1147--1151",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "6",

}

TY - JOUR

T1 - Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis

AU - Mazzuca, Steven A.

AU - Poole, A. Robin

AU - Brandt, Kenneth D.

AU - Katz, Barry

AU - Lane, Kathleen A.

AU - Lobanok, Tatiana

PY - 2006/6

Y1 - 2006/6

N2 - Objective. We examined whether plasma concentrations of biomarkers of the collagenase cleavage of type II collagen (C2C), types I and II collagens (C1,2C), type II collagen synthesis (CPII), proteoglycan aggrecan turnover (CS846), and the ratio C2C:CPII would distinguish subjects with progressive radiographic osteoarthritis (OA) from those with stable disease. Methods. Subjects were 120 obese middle-aged women with unilateral knee OA who participated in a 30-month clinical trial of structure modification with doxycycline, in which a standardized semiflexed anteroposterior view of the knee was obtained at baseline, 16 months, and 30 months. Subjects were selected from a larger sample to permit a priori comparisons between 60 OA progressors and 60 non-progressors, as defined by joint space narrowing (JSN) in the medial tibiofemoral compartment. Each group contained 30 subjects who exhibited clinically significant increases in knee pain over 30 months and 30 who did not. Plasma samples were obtained every 6 months for determination of C2C, CPII, CS846, and C1,2C. Results. None of the biomarkers was a significant predictor of progression of JSN. Over the interval from baseline to 16 months, the mean and the maximum of the intercurrent CS846 values were significantly associated with JSN (i.e., 0.12-0.14 mm of JSN per SD decrease in mean or maximum CS846; p <0.01). The mean of serial CS846 levels was related to JSN also during the interval between months 16 and 30. Conclusion. Markers of type II collagen synthesis/degradation and of proteoglycan aggrecan turnover were not predictive of JSN in knee OA in this pilot study. However, serial concentrations of proteoglycan aggrecan epitope CS846 were associated with JSN during both the intervals studied.

AB - Objective. We examined whether plasma concentrations of biomarkers of the collagenase cleavage of type II collagen (C2C), types I and II collagens (C1,2C), type II collagen synthesis (CPII), proteoglycan aggrecan turnover (CS846), and the ratio C2C:CPII would distinguish subjects with progressive radiographic osteoarthritis (OA) from those with stable disease. Methods. Subjects were 120 obese middle-aged women with unilateral knee OA who participated in a 30-month clinical trial of structure modification with doxycycline, in which a standardized semiflexed anteroposterior view of the knee was obtained at baseline, 16 months, and 30 months. Subjects were selected from a larger sample to permit a priori comparisons between 60 OA progressors and 60 non-progressors, as defined by joint space narrowing (JSN) in the medial tibiofemoral compartment. Each group contained 30 subjects who exhibited clinically significant increases in knee pain over 30 months and 30 who did not. Plasma samples were obtained every 6 months for determination of C2C, CPII, CS846, and C1,2C. Results. None of the biomarkers was a significant predictor of progression of JSN. Over the interval from baseline to 16 months, the mean and the maximum of the intercurrent CS846 values were significantly associated with JSN (i.e., 0.12-0.14 mm of JSN per SD decrease in mean or maximum CS846; p <0.01). The mean of serial CS846 levels was related to JSN also during the interval between months 16 and 30. Conclusion. Markers of type II collagen synthesis/degradation and of proteoglycan aggrecan turnover were not predictive of JSN in knee OA in this pilot study. However, serial concentrations of proteoglycan aggrecan epitope CS846 were associated with JSN during both the intervals studied.

KW - Biomarkers

KW - Knee osteoarthritis

KW - Type II collagen

UR - http://www.scopus.com/inward/record.url?scp=33744744388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744744388&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 1147

EP - 1151

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 6

ER -